Poster is available to registered attendees only via the ASH annual meeting virtual platform, as per congress regulations. 

Session Name: 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III

Session Date: Monday, December 8, 2025

Presentation Time:  06:00 PM - 08:00 PM EST

Location: Orange County Convention Center, Orlando, Florida, USA 

Link to Published Abstract

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Emapalumab induces rapid, durable responses and reliable bridging to curative HSCT in patients with primary HLH: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09

Michael B. Jordan, Franco Locatelli, Didier Halimi, Elena Burillo, Brian D. Jamieson, Andrew Danquah, Emmanuel Monnet

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Quality of life and functional improvements with efanesoctocog alfa in patients with moderate to severe hemophilia A: A real-world survey 

Maissaa Janbain, Miguel A. Escobar, Manuel Carcao , Nathan Ball, Ella Morton, Duygu Bozkaya, Sylvie Bozzi, Nicole Tsao, Andrew Wilson

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib following a switch from ruxolitinib: The MY-PAC Study

Douglas Tremblay, Abiola Oladapo, Michael Marrone, Puja Aggarwal, Caleb Paydar, Djibril Liassou, Purvi Suthar, Adina Geprifti, Michael Vredenburg , Bruce Feinberg, James Rossetti, Naveen Pemmaraju

Publication
  • AMCP Nexus •
  • 28 October, 2025 •
  • •

Healthcare Resource Utilization in Patients with Primary Immune Thrombocytopenia Treated with Avatrombopag in the United States: REAL-AVA 2.0 Study Results

Abiola Oladapo, Srikanth Nagalla, Moshe Y Levy, Shruti Chaturvedi, Scott Kolodny, Chelsea Bernheisel, Elyse Swallow, Debbie Goldschmidt, Alexandra Greatsinger, Loren Ormenaj, Sinia Sareen, Michael Vredenburg

Available materials

Poster
Publication
  • JSH •
  • 10 October, 2025 •
  • •

One-year efficacy and safety of avatrombopag for chronic immune thrombocytopenia in Japanese adults

Hiroki Yamaguchi, Masaki Iino, Yoshiaki Tomiyama , Harumi Kamiya, Jessica Zhang, Nina Skuban

Available materials

Oral Presentation
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Real-World Outcomes of Avatrombopag Treatment in Primary ITP Stratified by Prior TPO-RA Exposure

Srikanth Nagalla, Moshe Y Levy, Shruti Chaturvedi, Scott Kolodny, Abiola Oladapo, Chelsea Bernheisel, Elyse Swallow, Debbie Goldschmidt, Alexandra Greatsinger, Loren Ormenaj, Sinia Sareen, Michael Vredenburg

Available materials

Oral Presentation
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Analysis of Baseline Influences on Platelet Response to Avatrombopag (AVA) from a Phase 3b Multicenter, Randomized, Double-Blind, Placebo (PBO)-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of AVA for the Treatment of Pediatric Pati

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Amanda Grimes, Michele Lambert, Jessica Zhang, Brian D. Jamieson, Michael Vredenburg , Scott Kolodny

Available materials

Poster
Sign up for alerts